ACRX
Acelrx Pharmaceuticals Inc
$0.86
Earnings Summary
Revenue | $0.12Mn |
Net Profits | $-1.36Mn |
Net Profit Margins | -1159.83% |
Highlights
Acelrx Pharmaceuticals Inc’s revenue fell -76.92% since last year same period to $0.12Mn in the Q3 2023. On a quarterly growth basis, Acelrx Pharmaceuticals Inc has generated -53.75% fall in its revenue since last 3-months.
Acelrx Pharmaceuticals Inc’s net profit jumped 79.9% since last year same period to $-1.36Mn in the Q3 2023. On a quarterly growth basis, Acelrx Pharmaceuticals Inc has generated 68.95% jump in its net profits since last 3-months.
Acelrx Pharmaceuticals Inc’s net profit margin jumped 12.88% since last year same period to -1159.83% in the Q3 2023. On a quarterly growth basis, Acelrx Pharmaceuticals Inc has generated 32.87% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Acelrx Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.18 |
EPS Estimate Current Year | -0.18 |
Highlights
Acelrx Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.18 - a 35.71% jump from last quarter’s estimates.
Acelrx Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.18.
Key Ratios
Key ratios of the Acelrx Pharmaceuticals Inc post its Q3 2023 earnings
Earning Per Share (EPS) | -0.08 |
Highlights
Acelrx Pharmaceuticals Inc’s earning per share (EPS) jumped 91.49% since last year same period to -0.08 in the Q3 2023. This indicates that the Acelrx Pharmaceuticals Inc has generated 91.49% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-10 | -0.53 | -0.4 | 24.53% |
2023-05-10 | -1.39 | -0.75 | 46.04% |
2023-11-14 | -0.28 | -0.08 | 71.43% |
₹0 US Stocks a/c Opening Fee